Last 12 months
Inside the activity.
4 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2024 Filed Mar 27, 2024 21:25 UTC |
Lundberg Sven AnteDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,767 | $0.00 Strike: $16.82 | $0.00 |
DisclosureSEC source: 0000950170-24-037368 · ownership.xml · derivative · entry 1 Lundberg Sven Ante · CIK 0001682126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,767 Underlying: Common Stock · 12,767 shares Expires 2034-03-24 F1 · derivative.exercise_date: One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 18,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 3 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionCommon Stock | 23,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037196 · ownership.xml · derivative · entry 3 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,088 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037196 · ownership.xml · derivative · entry 2 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,088 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionCommon Stock | 6,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-037196 · ownership.xml · nonDerivative · entry 1 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 25, 2024 Filed Apr 23, 2024 21:03 UTC |
Alloway PaulSee Remarks
|
SaleCommon Stock | 268 | $24.21 | $6,488.28 |
DisclosureSEC source: 0000950170-24-047031 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,596 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs. F2 · shares: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. F2 · balance_after: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| March 25, 2024 Filed Apr 23, 2024 21:00 UTC |
Michaud Charles JrSee Remarks
|
SaleCommon Stock | 75 | $24.20 | $1,815.00 |
DisclosureSEC source: 0000950170-24-047018 · ownership.xml · nonDerivative · entry 1 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 927 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs. F2 · shares: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. F2 · balance_after: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| March 25, 2024 Filed Aug 14, 2024 20:05 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,095 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-096986 · ownership.xml · derivative · entry 3 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock. F2 · shares: The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split. F4 · derivative.exercise_date: The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date. F4 · derivative.expiration_date: The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date. Read SEC document |
| March 25, 2024 Filed Aug 14, 2024 20:05 UTC |
TZIANABOS ARTHURDirector
|
SaleCommon Stock | 265 | $24.20 | $6,413.00 |
DisclosureSEC source: 0000950170-24-096986 · ownership.xml · nonDerivative · entry 2 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,983 F3 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| March 25, 2024 Filed Aug 14, 2024 20:05 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionCommon Stock | 1,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-096986 · ownership.xml · nonDerivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock. F2 · balance_after: The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| January 09, 2024 Filed Feb 15, 2024 21:33 UTC |
TZIANABOS ARTHURDirector
|
SaleCommon Stock | 13,037 | $0.57 | $7,445.43 |
DisclosureSEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 3 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,778 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5710 to $0.5712. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:54 UTC |
Alloway PaulSee Remarks
|
SaleCommon Stock | 7,280 | $0.57 | $4,120.48 |
DisclosureSEC source: 0000950170-24-002572 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,036 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units. F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.058 to $0.58. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:49 UTC |
Michaud Charles JrSee Remarks
|
SaleCommon Stock | 1,708 | $0.57 | $975.27 |
DisclosureSEC source: 0000950170-24-002563 · ownership.xml · nonDerivative · entry 1 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,598 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units. F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.571 to $0.584. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 8,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 6 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,090 Underlying: Common Stock · 8,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 5 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,440 Underlying: Common Stock · 5,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 4,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 4 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. F2 · derivative.expiration_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionCommon Stock | 8,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 3 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionCommon Stock | 5,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Alloway PaulSee Remarks
|
Exercise / conversionCommon Stock | 4,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 2,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 6 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 2,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 5 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,088 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle as to 1,056 shares on January 1, 2024 and 1,008 shares on January 1, 2025. The RSUs do not have an expiration date. F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle as to 1,056 shares on January 1, 2024 and 1,008 shares on January 1, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 4 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The RSUs vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. F2 · derivative.expiration_date: The RSUs vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionCommon Stock | 2,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 3 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionCommon Stock | 1,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 2 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC |
Michaud Charles JrSee Remarks
|
Exercise / conversionCommon Stock | 544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 1 Michaud Charles Jr · CIK 0001999011 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Feb 15, 2024 21:33 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 19,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015944 · ownership.xml · derivative · entry 5 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,720 Underlying: Common Stock · 19,140 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. F5 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Feb 15, 2024 21:33 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 14,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015944 · ownership.xml · derivative · entry 4 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs are fully vested and do not have an expiration date. F4 · derivative.expiration_date: The RSUs are fully vested and do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Feb 15, 2024 21:33 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionCommon Stock | 19,140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 2 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Feb 15, 2024 21:33 UTC |
TZIANABOS ARTHURDirector
|
Exercise / conversionCommon Stock | 14,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:44 UTC |
Seymour AlbertDirector · See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 4,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-047302 · ownership.xml · derivative · entry 3 Seymour Albert · CIK 0001735324 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,380 Underlying: Common Stock · 4,620 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:44 UTC |
Seymour AlbertDirector · See Remarks
|
SaleCommon Stock | 1,448 | $1.15 | $1,665.49 |
DisclosureSEC source: 0000950170-23-047302 · ownership.xml · nonDerivative · entry 2 Seymour Albert · CIK 0001735324 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,874 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:44 UTC |
Seymour AlbertDirector · See Remarks
|
Exercise / conversionCommon Stock | 4,620 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-047302 · ownership.xml · nonDerivative · entry 1 Seymour Albert · CIK 0001735324 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 9 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F5 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 8 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F4 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 7 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F4 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
SaleCommon Stock | 1,308 | $1.39 | $1,818.12 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 6 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,496 F3 · shares: The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionCommon Stock | 4,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 5 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
SaleCommon Stock | 109 | $1.39 | $151.51 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 4 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,160 F2 · shares: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionCommon Stock | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 3 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
SaleCommon Stock | 436 | $1.39 | $606.04 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 2 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,882 F2 · shares: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 01:39 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionCommon Stock | 1,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 1 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:08 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-038564 · ownership.xml · derivative · entry 3 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3 · derivative.exercise_date: The restricted stock units vested and settled in full on August 2, 2023. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:08 UTC |
Jordan JulieChief Medical Officer
|
SaleCommon Stock | 99 | $1.31 | $129.69 |
DisclosureSEC source: 0000950170-23-038564 · ownership.xml · nonDerivative · entry 2 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,770 F2 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:08 UTC |
Jordan JulieChief Medical Officer
|
Exercise / conversionCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-038564 · ownership.xml · nonDerivative · entry 1 Jordan Julie · CIK 0001968554 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 22:09 UTC |
Poulton Jeffrey V.Director
|
GrantOption (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-23-028383 · ownership.xml · derivative · entry 1 Poulton Jeffrey V. · CIK 0001782962 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 18:33 UTC |
Patterson Matthew RDirector
|
GrantOption (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-23-028411 · ownership.xml · derivative · entry 1 Patterson Matthew R · CIK 0001401018 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 23:25 UTC |
GILLIS STEVENDirector
|
GrantOption (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-23-028428 · ownership.xml · derivative · entry 1 GILLIS STEVEN · CIK 0001229592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2023-06-14 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 22:17 UTC |
Thistle MaryDirector
|
GrantOption (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-23-028396 · ownership.xml · derivative · entry 1 Thistle Mary · CIK 0001317917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.